Hipromine (WAR:HPM) Ending Cash Position: zł9.67 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:HPM Hipromine SA WAR:HPM
55 GF Score
Price zł66.50
GF Value zł520.12
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Hipromine Ending Cash Position?

Hipromine WAR:HPM -2.21% 55 Ending Cash Position is zł9.67 Mil as of Jun. 2026. GuruFocus rates WAR:HPM with a GF Score™ of 55/100 and a GF Value™ of zł520.12 (Possible Value Trap). The stock has 8 warning signs investors should review.

Hipromine's Ending Cash Position for the quarter that ended in Jun. 2026 was zł9.67 Mil.

Hipromine's quarterly Ending Cash Position declined from Dec. 2025 (zł32.63 Mil) to Mar. 2026 (zł17.34 Mil) and declined from Mar. 2026 (zł17.34 Mil) to Jun. 2026 (zł9.67 Mil).

Hipromine's annual Ending Cash Position increased from Dec. 2023 (zł15.79 Mil) to Dec. 2024 (zł31.00 Mil) and increased from Dec. 2024 (zł31.00 Mil) to Dec. 2025 (zł32.63 Mil).


Hipromine Ending Cash Position Related Terms


Hipromine Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Hipromine's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hipromine Ending Cash Position Chart

Hipromine Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 17.26 5.97 15.79 31.00 32.63

Hipromine Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.75 42.56 32.63 17.34 9.67
WAR:HPM
55GF Score
Hipromine SA WAR:HPM
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hipromine Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Hipromine's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=30.998+1.632
=32.63

Hipromine's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=17.339+-7.667
=9.67

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of zł9.67 Mil mean?
Hipromine (WAR:HPM) has a Ending Cash Position of zł9.67 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Hipromine and its competitors.
Is Hipromine's Ending Cash Position too high?
Hipromine's current Ending Cash Position is zł9.67 Mil. Overall, Hipromine has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hipromine's Ending Cash Position compare to KHC and GIS?
Hipromine's Ending Cash Position of zł9.67 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Consumer Packaged Goods company?
A good Ending Cash Position depends on the Consumer Packaged Goods industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Hipromine and its competitors. Hipromine's current Ending Cash Position is zł9.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hipromine stock overvalued right now?
Based on GuruFocus' analysis, Hipromine (WAR:HPM) is currently considered Possible Value Trap. The stock's GF Value™ is zł520.12, compared to a current price of zł66.50 — trading 87.2% below its estimated fair value. The current Ending Cash Position is zł9.67 Mil. Hipromine's overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Hipromine (WAR:HPM), the current Ending Cash Position is zł9.67 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hipromine (WAR:HPM) Overvalued in 2026?

Based on GuruFocus' analysis, Hipromine stock appears to be undervalued. The current stock price of zł66.50 is trading 87.2% below its estimated GF Value™ of zł520.12. GuruFocus considers Hipromine to be Possible Value Trap.

Key valuation signals for WAR:HPM:

  • Ending Cash Position: zł9.67 Mil
  • GF Value™: zł520.12 vs. price of zł66.50 (87.2% below fair value)
  • GF Score™: 55/100 with 8 warning signs

No single metric tells the full story. See the WAR:HPM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hipromine Business Description

Address ul. Poznańska, 12th Floor, Robakowo, POL, 62-023
Hipromine SA is a European scale supplier of an alternative protein produced through innovative, proprietary technology of industrial insect breeding. The company's offer is directed mainly to the market of pet food and fodder for fish farming, as well as livestock and horticulture.
55GF Score

Get the complete analysis for WAR:HPM

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł66.50
Price
zł520.12
GF Value